I agree that this site is using cookies. You can find further informations here.
X
Vaccaro, Angela
127  results:
OpenAccess-fulltext X
?
1

The prognostic relevance of HER2-positivity gain in metasta..:

Pizzuti, Laura ; Barba, Maddalena ; Mazzotta, Marco...
info:eu-repo/semantics/altIdentifier/pmid/34215766.  , 2021
Link: https://hdl.handle.net/1..
 
?
2

The prognostic relevance of HER2-positivity gain in metasta..:

Pizzuti, Laura ; Barba, Maddalena ; Mazzotta, Marco...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253801/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
3

The prognostic relevance of HER2-positivity gain in metasta..:

Pizzuti, Laura ; Barba, Maddalena ; Mazzotta, Marco...
info:eu-repo/semantics/altIdentifier/pmid/34215766.  , 2021
Link: http://hdl.handle.net/11..
 
?
4

Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane ..:

Orlandi, Armando ; Iattoni, Elena ; Pizzuti, Laura...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766166/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
5

Distinct HR expression patterns significantly affect the cl..:

Pizzuti, Laura ; Krasniqi, Eriseld ; Barchiesi, Giacomo...
info:eu-repo/semantics/altIdentifier/pmid/31330065.  , 2020
Link: http://hdl.handle.net/11..
 
?
6

A multicenter REtrospective observational study of first-li..:

Gamucci, Teresa ; Pizzuti, Laura ; Natoli, Clara...
info:eu-repo/semantics/altIdentifier/pmid/30403909.  , 2019
Link: http://hdl.handle.net/11..
 
?
7

Distinct HR expression patterns significantly affect the cl..:

Pizzuti, Laura ; Krasniqi, Eriseld ; Barchiesi, Giacomo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027476/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
8

Palbociclib plus endocrine therapy in HER2 negative, hormon..:

Pizzuti, Laura ; Giordano, Antonio ; Michelotti, Andrea...
info:eu-repo/semantics/altIdentifier/pmid/30536609.  , 2018
Link: http://hdl.handle.net/10..
 
?
9

Neoadjuvant chemotherapy in triple-negative breast cancer: ..:

Gamucci, Teresa ; Pizzuti, Laura ; Sperduti, Isabella...
info:eu-repo/semantics/altIdentifier/pmid/28710865.  , 2018
Link: https://hdl.handle.net/1..
 
?
10

A multicenter REtrospective observational study of first-li..:

Gamucci, Teresa ; Pizzuti, Laura ; Natoli, Clara...
info:eu-repo/semantics/altIdentifier/pmid/30403909.  , 2018
Link: http://hdl.handle.net/11..
 
?
11

Body Mass Index and Treatment Outcomes in Metastatic Breast..:

Barba, Maddalena ; Pizzuti, Laura ; Sperduti, Isabella...
info:eu-repo/semantics/altIdentifier/pmid/26449308.  , 2016
Link: http://hdl.handle.net/11..
 
?
12

A Real‐World Multicentre Retrospective Study of Paclitaxel‐..:

Gamucci, Teresa ; Mentuccia, Lucia ; Natoli, Clara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220933/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
13

Outcomes of HER2-positive early breast cancer patients in t..:

Vici, Patrizia ; Pizzuti, Laura ; Natoli, Clara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
14

Eribulin Mesylate in Pretreated Breast Cancer Patients: A M..:

Gamucci, Teresa ; Michelotti, Andrea ; Pizzuti, Laura...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982178.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
15

The prognostic relevance of HER2-positivity gain in metasta..:

Laura Pizzuti ; Maddalena Barba ; Marco Mazzotta...
https://doi.org/10.1038/s41598-021-92774-z.  , 2021
Link: https://doi.org/10.1038/..
 
1-15